An unexpected drug-drug interaction has been recently reported between dolutegravir, an HIV integrase inhibitor, and valproic acid. Despite there being several potential underlying mechanisms, plasma protein displacement has been suggested. The aim of this study was to assess plasma concentrations of several antiretrovirals when administered with or without valproic acid.
Antiretroviral concentrations in the presence and absence of valproic acid
Calcagno, A;
2020-01-01
Abstract
An unexpected drug-drug interaction has been recently reported between dolutegravir, an HIV integrase inhibitor, and valproic acid. Despite there being several potential underlying mechanisms, plasma protein displacement has been suggested. The aim of this study was to assess plasma concentrations of several antiretrovirals when administered with or without valproic acid.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ARVs VPA Calcagno JAC 2020.pdf
file disponibile solo agli amministratori
Licenza:
DRM non definito
Dimensione
315.61 kB
Formato
Adobe PDF
|
315.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
